Navigation Links
Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
Date:2/14/2008

WEIFANG, Shandong Province, China, Feb. 14 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today reported financial results for the three months ended December 31, 2007.

Second Quarter of Fiscal 2008 Highlights

-- Net sales increased 102.7% to $25.0 million

-- Gross profit rose 91% to $5.9 million

-- Gross profit margin was 23.5%

-- Operating income increased 121.2% to $4.1 million

-- Net income increased 97% to $3.1 million

-- Weighted avg. diluted shares outstanding were 20.3 million vs. 10.1

million

-- Fully diluted EPS was $0.15 versus $0.16

Second Quarter of Fiscal 2008 Results

For the second quarter of fiscal 2008, net revenues increased 102.7% to $25.0 million from $12.3 million for the second quarter of fiscal 2007. This increase was largely due to more cornstarch production, higher product prices, diversification of product lines and the expansion of higher-value products. The Company raised the sales of cornstarch, which constituted a higher proportion of total sales revenue compared to the same reporting period last year. Although cornstarch had a lower gross profit margin, the Company nevertheless increased its production to generate necessary working capital and funds for construction of its new glucose complex.

In addition to its pharmaceutical glucose series of products and cornstarch, the Company also produced significant amounts of other non- medicinal glucose or cornstarch related products. The sales revenues generated from these products were approximately 5.9 times of those the same period last year, and constituted approximately 26.6% of its total sales revenues for the six months ended December 31, 2007.

"We continued to see strong growth in second quarter of
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
2. Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
3. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
4. Shengtai Pharmaceutical, Inc. to Present at Roth Conference
5. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
6. BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
9. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynchs Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- In books and movies, plots involving older men chasing ... research suggests that the stereotype may be grounded in fact. ... more than 12,000 people from Finland. The researchers, led ... that women typically preferred men who were the same age ... On the other hand, men tended to have a ...
(Date:9/30/2014)... Red Bank, New Jersey (PRWEB) September 30, 2014 ... Jersey’s largest not-for-profit visiting nurse association—is pleased to announce ... officer, was honored with a NJBIZ “40 Under ... 40 of New Jersey’s most accomplished young businessmen and ... and who share a commitment to business growth, professional ...
(Date:9/30/2014)... 2014 AxoGen, Inc. (NASDAQ: AXGN), ... peripheral nerve repair market, announced the presentation of clinical ... Society for Surgery of the Hand (ASSH) 2014 Annual ... , The ASSH Best Paper Award was ... Nerve Allografts for Large Gap Nerve Discontinuities: Outcomes From ...
(Date:9/30/2014)... SOLON, OH (PRWEB) September 30, 2014 ... wiper blades sporting the iconic pink ribbon in support ... October, a popular month for businesses and non-profits to ... this worthwhile cause. , AutoTex PINK is a woman-owned ... windshield wipers. They are committed to partnering with ...
(Date:9/30/2014)... September 30, 2014 ... , From:        Hope For The ... abarnwell(at)hopeforthewarriors(dot)org , Event:        Got ... , Date:        Thursday, October 2, ... and Navy Club, 901 ...
Breaking Medicine News(10 mins):Health News:When It Comes to Sex Partners, Men Prefer Younger Women: Study 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 2Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 4Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 5Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 2Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 3Health News:Hope For The Warriors' Got Heart, Give Hope Celebration Media Advisory 2
... one of the most lethal cancers, with fewer than five ... new study that peers deeply into the genetics of pancreatic ... early diagnosis. In contrast to earlier predictions, many pancreatic tumors ... become lethal after the first genetic perturbations appear. "There ...
... People who regularly eat whole grains rather than refined grains ... a higher risk for heart disease and type 2 diabetes, ... (VAT) -- the fat that surrounds the intra-abdominal organs -- ... cholesterol and insulin resistance, health risk factors collectively known as ...
... , TUESDAY, Oct. 26 (HealthDay News) -- As many ... if people followed five simple healthy lifestyle recommendations, Danish ... overall health as well -- include exercise, a good ... weight, the researchers say. "Even a modest difference ...
... University and University of North Carolina (UNC) researchers report ... Research that narcotics and diagnostic testing are overused ... may overlook more effective treatments for neck pain, such ... study, evidence to support the effectiveness of therapeutic exercise ...
... Steven Reinberg HealthDay Reporter , TUESDAY, Oct. 26 ... the blood-thinning drug Plavix (clopidogrel) may be at increased risk ... finds. Having the gene variants seems to reduce the ... developing blood clots in the stent, suffering a heart attack ...
... -- Children who survive cancer face an increased risk ... The findings highlight the increased need for long-term ... researchers said. "Current treatments have dramatically increased survival ... many cancer therapies -- including surgery, radiation, and chemotherapy ...
Cached Medicine News:Health News:Revising the timeline for deadly pancreatic cancer 2Health News:Revising the timeline for deadly pancreatic cancer 3Health News:Eating Whole Grains, Fewer Refined Grains, May Help Heart 2Health News: Healthy Living Can Prevent Nearly 25% of Colorectal Cancers 2Health News: Healthy Living Can Prevent Nearly 25% of Colorectal Cancers 3Health News:Narcotics and diagnostics overused in treatment of chronic neck pain 2Health News:Gene Mutations May Blunt Plavix's Effectiveness, Study Finds 2Health News:Gene Mutations May Blunt Plavix's Effectiveness, Study Finds 3Health News:Childhood Cancer Survivors Risk Future GI Problems 2
(Date:9/30/2014)... DIEGO , Sept. 30, 2014 ... three-dimensional biology company focused on delivering breakthrough 3D ... Liver Model has been selected as a finalist in ... 2014 Most Innovative New Product Awards, sponsored by ... of innovative technology and life sciences products in ...
(Date:9/30/2014)... -- The Corporate Whistleblower Center is urging ER doctors, ... if they have well documented proof of a ... sent home, as an intentional way to overbill ... the Center would like to explain. http://CorporateWhistleblowerCenter.Com ... Photo - http://photos.prnewswire.com/prnh/20140929/149017 ...
(Date:9/30/2014)... EXECUTIVE SUMMARY The present report ... - Increasing Demand from Ageing Population to Drive ... past, present and future outlook. The report discusses ... market with outlook to 2017. Statistics include functional ... sub-segments of the industry, ongoing trends and developments, ...
Breaking Medicine Technology:Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 2Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 3Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 4North America Nutraceuticals Industry Outlook to 2017- Increasing Demand from Ageing Population to Drive Growth 2North America Nutraceuticals Industry Outlook to 2017- Increasing Demand from Ageing Population to Drive Growth 3
... 5 pages of various contrast levels showing 5 ... 9.5M. Contrast levels are 25%, 10%, 5%, 2.5% ... at several different distances. These two sets are ... different set of symbols to guard against ...
Directional `E' and `C' test....
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
... recording unit suitable for a wide range ... up to 16 input channels. Examples include ... unit is capable of recording at speeds ... second continuously to disk, and is compatible ...
Medicine Products: